Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), ...
Following what was described as Formosa Group CEO Bob Rosenthal’s emotional last day with his team, there’s more developing at the leading audio postproduction company. Rosenthal’s last official day ...
Formosa Pharmaceuticals has handed over another set of regional rights to its near-approval eye drug candidate APP13007, striking a deal that positions Cristália Produtos Químicos Farmacêuticos to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback